A randomized controlled trial of vitamin D3 supplementation in African American women

Archives of Internal Medicine

Volumn 165, Issue 14, 2005, Pages 1618-1623

  Aloia, John F ^a   Talwar, Sonia Arunabh ^a   Pollack, Simcha ^a   Yeh, James ^a  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; COLECALCIFEROL; PARATHYROID HORMONE; PLACEBO;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE TURNOVER; CALCIUM INTAKE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; ETHNOLOGY; FEMALE; HIP; HORMONE DETERMINATION; HUMAN; HYPERCALCEMIA; LUMBAR SPINE; METABOLITE; NEPHROLITHIASIS; NORMAL HUMAN; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; POSTMENOPAUSE; PRIORITY JOURNAL; RADIUS; RANDOMIZED CONTROLLED TRIAL; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

AFRICAN AMERICANS; AGED; BIOLOGICAL MARKERS; BONE DENSITY; CALCIUM; CHOLECALCIFEROL; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MIDDLE AGED; PARATHYROID HORMONE; POSTMENOPAUSE; TIME FACTORS; TREATMENT OUTCOME;

EID: 23744466481     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.165.14.1618     Document Type: Article

References (37)

1. Osteoporosis prevention, diagnosis, and therapy. NIH Consens Statement. 2000;17:1-45.
2. Heaney RP. Lessons for nutritional science from vitamin D. Am J Clin Nutr. 1999;69:825-826.
3. Burckhardt P. Calcium and vitamin D in osteoporosis: supplementation or treatment? Calcif Tissue Int. 2002;70:74-77.
4. Chapuy MC, Preziosi P, Maamer M, et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int. 1997;7:439-443.
5. 3 supplements. Osteoporos Int. 2001;12:875-879.
6. 3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr. 2001;73:288-294.
7. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med. 1997;337:670-676.
8. 3 and calcium to prevent hip fractures in the elderly women. N Engl J Med. 1992;327:1637-1642.
9. Lips P, Graafmans WC, Ooms ME, Bezemer PD, Bouter LM. Vitamin D supplementation and fracture incidence in elderly persons: a randomized, placebo-controlled clinical trial. Ann Intern Med. 1996;124:400-406.
10. Ooms ME, Roos JC, Bezemer PD, van der Vijgh WJ, Bouter LM, Lips P. Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial. J Clin Endocrinol Metab. 1995;80:1052-1058.
11. Cooper L, Clifton-Bligh PB, Nery ML, et al. Vitamin D supplementation and bone mineral density in early postmenopausal women. Am J Clin Nutr. 2003;77:1324-1329.
12. Hunter D, Major P, Arden N, et al. A randomized controlled trial of vitamin D supplementation on preventing postmenopausal bone loss and modifying bone metabolism using identical twin pairs. J Bone Miner Res. 2000;15:2276-2283.
13. 3 (cholecalciferol) supplementation on fractures and mortality in men and women living the community: randomised double blind controlled trial. BMJ. 2003;326:469.
14. Baeksgaard L, Andersen KP, Hyldstrup L. Calcium and vitamin D supplementation increases spinal BMD in healthy, postmenopausal women. Osteoporos Int. 1998;8:255-260.
15. 3 prevent postmenopausal bone loss? Calcif Tissue Int. 1986;39:128-132.
16. Papadimitropoulos E, Wells G, Shea B, et al. Meta-analyses of therapies for postmenopausal osteoporosis, VIII: meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women. Endocr Rev. 2002;23:560-569.
17. Heaney RP. The bone remodeling transient: interpreting interventions involving bone-related nutrients. Nutr Rev. 2001;59:327-334.
18. Aloia JF, Vaswani A, Yeh JK, Flaster E. Risk for osteoporosis in black women. Calcif Tissue Int. 1996;59:415-423.
19. Meier DE, Luckey MM, Wallenstein S, Lapinski RH, Catherwood B. Racial differences in pre- and postmenopausal bone homeostasis: association with bone density. J Bone Miner Res. 1992;7:1181-1189.
20. Nesby-O'Dell S, Scanlon KS, Cogswell ME, et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr. 2002;76:187-192.
21. Kyriakidou-Himonas M, Aloia JF, Yeh JK. Vitamin D supplementation in postmenopausal black women. J Clin Endocrinol Metab. 1999;84:3988-3990.
22. Kao PC, Jiang NS, Klee GG, Purnell DC. Development and validation of a new radioimmunoassay for parathyrin (PTH). Clin Chem. 1982;28:69-74.
23. Hollis B. Relative concentrations of 25-hydroxyvitamin D2/D3 and 1,25-dihydroxyvitamin D2/D3 in maternal plasma at delivery. Nutr Res. 1984;4:27.
24. Hollis BW. Assay of circulating 1,25-dihydroxyvitamin D involving a novel single-cartridge extraction and purification procedure. Clin Chem. 1986;32:2060-2063.
25. Jacobsen SJ, Goldberg J, Miles TP, Brody JA, Stiers W, Rimm AA. Hip fracture incidence among the old and very old: a population-based study of 745,435 cases. Am J Public Health. 1990;80:871-873.
26. Finkelstein JS, Lee ML, Sowers M, et al. Ethnic variation in bone density in premenopausal and early perimenopausal women: effects of anthropometric and lifestyle factors. J Clin Endocrinol Metab. 2002;87:3057-3067.
27. Nelson DA, Barondess DA, Hendrix SL, Beck TJ. Cross-sectional geometry, bone strength, and bone mass in the proximal femur in black and white postmenopausal women. J Bone Miner Res. 2000;15:1992-1997.
28. Bryant RJ, Wastney ME, Martin BR, et al. Racial differences in bone turnover and calcium metabolism in adolescent females. J Clin Endocrinol Metab. 2003;88:1043-1047.
29. Aloia JF, Mikhail M, Pagan CD, Arunachalam A, Yeh JK, Flaster E. Biochemical and hormonal variables in black and white women matched for age and weight. J Lab Clin Med. 1998;132:383-389.
30. Cosman F, Morgan DC, Nieves JW, et al. Resistance to bone resorbing effects of PTH in black women. J Bone Miner Res. 1997;12:958-966.
31. Heaney RP. The importance of calcium intake for lifelong skeletal health. Calcif Tissue Int. 2002;70:70-73.
32. 3 dietary supplementation on bone loss at the hip in men and women over the age of 60. J Clin Endocrinol Metab. 2000;85:3011-3019.
33. Lips P, Duong T, Oleksik A, et al. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the Multiple Outcomes of Raloxifene Evaluation Clinical Trial. J Clin Endocrinol Metab. 2001;86:1212-1221.
34. Recker RR, Hinders S, Davies KM, et al. Correcting calcium nutritional deficiency prevents spine fractures in elderly women. J Bone Miner Res. 1996;11:1961-1966.
35. Reid IR, Ames RW, Evans MC, Gamble GD, Sharpe SJ. Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial. Am J Med. 1995;98:331-335.
36. Riggs BL, O'Fallon WM, Muhs J, O'Connor MK, Kumar R, Melton LJ III. Long-term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in elderly women. J Bone Miner Res. 1998;13:168-174.
37. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999;69:842-856.